Company Filing History:
Years Active: 2025
Title: Huizhu Liu: Innovator in Adenoviral Expression Technology
Introduction
Huizhu Liu is a prominent inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the development of adenoviral expression vectors. Her innovative work has the potential to advance therapeutic applications and enhance gene delivery systems.
Latest Patents
Huizhu Liu holds a patent for an adenoviral expression vector and methods for production. This patent includes a unique adenovirus expression vector that features mutations rendering it replication incompetent. Additionally, it encompasses nucleotide sequences encoding proteins or RNA. The patent outlines a method for synthesizing the adenovirus vector, which involves producing overlapping adenovirus sub-fragments, circularizing them into plasmid structures, and assembling them into a linear structure. Furthermore, her work includes the development of a mammalian cell line capable of replicating adenoviral vectors, which expresses E1A and E1B gene products while lacking other adenovirus sequences.
Career Highlights
Huizhu Liu is currently employed at Lung Biotechnology Pbc, where she continues to push the boundaries of biotechnology. Her expertise in adenoviral vectors has positioned her as a key player in the field, contributing to advancements in gene therapy and vaccine development.
Collaborations
Some of her notable coworkers include Colin Exline and Sean Stevens, who collaborate with her on various projects within the company.
Conclusion
Huizhu Liu's innovative work in adenoviral expression technology exemplifies her commitment to advancing biotechnology. Her contributions are paving the way for new therapeutic solutions and enhancing our understanding of gene delivery systems.